investorscraft@gmail.com

Intrinsic ValueLNA Santé S.A. (LNA.PA)

Previous Close23.30
Intrinsic Value
Upside potential
Previous Close
23.30

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

LNA Santé SA operates as a key player in France’s healthcare sector, specializing in the management of retirement homes, medical rehabilitation centers, mental health clinics, and home hospital services. The company’s revenue model is anchored in long-term care contracts and fee-for-service arrangements, ensuring stable cash flows from both public and private payers. Its diversified portfolio across care segments mitigates reliance on any single service line, enhancing resilience against regulatory or demand fluctuations. Positioned in a fragmented market, LNA Santé leverages its regional expertise and operational scale to maintain cost efficiency while adhering to France’s stringent healthcare standards. The aging population in Europe, particularly in France, provides a structural tailwind for its core retirement home and rehabilitation services. However, competition from non-profit providers and public hospitals necessitates continuous investment in care quality and facility modernization to sustain its market share. The company’s focus on integrated care pathways—spanning acute, post-acute, and home-based services—positions it as a holistic provider in a sector increasingly prioritizing patient-centric models.

Revenue Profitability And Efficiency

LNA Santé reported revenue of €806.6 million for the period, with net income of €21.8 million, reflecting a modest net margin of approximately 2.7%. Operating cash flow of €82.1 million underscores solid cash generation, though capital expenditures of €12.2 million indicate ongoing investments in facility maintenance and upgrades. The diluted EPS of €2.04 suggests efficient use of equity capital despite sector-wide cost pressures.

Earnings Power And Capital Efficiency

The company’s operating cash flow-to-revenue ratio of ~10.2% demonstrates reasonable earnings power, though high debt levels may constrain near-term flexibility. With €75.1 million in cash against €876.4 million in total debt, interest coverage remains a focus area. Asset turnover appears stable given the capital-intensive nature of healthcare facilities.

Balance Sheet And Financial Health

LNA Santé’s balance sheet carries significant leverage, with total debt exceeding €876 million against a market cap of €245 million. While cash reserves provide liquidity, the debt-to-equity ratio suggests reliance on refinancing. The sector’s defensive cash flows may support debt servicing, but prolonged high interest rates could pressure financial metrics.

Growth Trends And Dividend Policy

Organic growth is likely tied to France’s aging demographics, with limited near-term expansion signals beyond maintenance capex. A dividend of €0.6 per share implies a payout ratio of ~29%, balancing shareholder returns with reinvestment needs. Revenue growth trends should align with broader healthcare inflation and occupancy rates in its facilities.

Valuation And Market Expectations

At a market cap of €245 million, the stock trades at ~12x trailing earnings, a discount to broader healthcare peers, reflecting its leveraged position and regional focus. The beta of 0.7 indicates lower volatility versus the market, typical for defensive healthcare operators.

Strategic Advantages And Outlook

LNA Santé’s regional density and integrated care model provide competitive moats, but scalability beyond France remains untested. Regulatory risks and labor costs are persistent headwinds. The outlook hinges on debt management and France’s healthcare funding policies, with long-term demand underpinned by demographic trends.

Sources

Company filings, Euronext Paris disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount